Antimalarial 4‐aminoquinolines: mode of action and pharmacokinetics

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Fundamental & Clinical Pharmacology

• Publication date

  1994-01-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1472-8206.1994.tb00774.xPMID 8181791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chloroquine kinetics in the undernourished

  2004cited by this paper
• Drug treatment and prevention of malaria

  2004cited by this paper
• Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis againstPlasmodium falciparum malaria

  2004cited by this paper
• Effect of dose size on amodiaquine pharmacokinetics after oral administration

  2004cited by this paper
• Efficacy of intramuscular amopyroquin for treatment of Plasmodium falciparum malaria in the Gabon Republic

  1993cited by this paper
• Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand.

  1993cited by this paper
• Chronotherapy of malaria: improved efficacy of timed chloroquine treatment of patients with Plasmodium falciparum infections.

  1992cited by this paper
• Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites

  1992cited by this paper
• Heme polymerase: modulation by chloroquine treatment of a rodent malaria.

  1992cited by this paper
• In vitro activities of chloroquine in combination with chlorpromazine or prochlorperazine against isolates of Plasmodium falciparum

  1992cited by this paper
• The chemotherapy of rodent malaria. XLVII. Studies on pyronaridine and other Mannich base antimalarials.

  1992cited by this paper
• Multidrug resistance in human cancer.

  1992cited by this paper
• Chloroquine-resistant Plasmodium vivax from Indonesia.

  1991cited by this paper
• Efficacy of amodiaquine against chloroquine-resistant malaria in Cameroon.

  1991cited by this paper
• Efficacy of amodiaquine against chloroquine-resistant malaria in Cameroon

  1991cited by this paper
• In vitro and in vivo potentiation of chloroquine against malaria parasites by an enantiomer of amlodipine

  1991cited by this paper
• Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7.

  1991cited by this paper
• Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated plasmodium falciparum malaria

  1991cited by this paper
• The disposition of amodiaquine in Zambians and Nigerians with malaria.

  1990cited by this paper
• Reversal of drug-resistant falciparum malaria by calcium antagonists: potential for host cell toxicity.

  1990cited by this paper
• Reactions of a free radical intermediate in the oxidation of amodiaquine.

  1990cited by this paper
• Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross

  1990cited by this paper
• Plasmodium vivax resistance to chloroquine?

  1989cited by this paper
• Chloroquine containing liposomes in the chemotherapy of murine malaria

  1989cited by this paper
• Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum.

  1989cited by this paper
• Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine.

  1989cited by this paper
• Pharmacokinetics of intramuscular amopyroquin in healthy subjects and determination of a therapeutic regimen for Plasmodium falciparum malaria

  1989cited by this paper
• Open comparison of intramuscular chloroquine and quinine in children with severe chloroquine-sensitive falciparum malaria.

  1989cited by this paper
• A comparison of the in vitro activities of amodiaquine and desethylamodiaquine against isolates of Plasmodium falciparum.

  1989cited by this paper
• Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum.

  1989cited by this paper
• Disposition of amopyroquin in rats and rabbits and in vitro activity against Plasmodium falciparum

  1988cited by this paper
• Parasitologic and clinical efficacy of 25 and 50 mg/kg of chloroquine for treatment of Plasmodium falciparum malaria in Rwandan children.

  1988cited by this paper
• Drug-protein conjugates--XIV. Mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man.

  1988cited by this paper
• Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine.

  1988cited by this paper
• Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations.

  1988cited by this paper
• Tissue Distribution and Excretion of Amodiaquine in the Rat

  1988cited by this paper
• Current concepts and new ideas on the mechanism of action of quinoline-containing antimalarials.

  1987cited by this paper
• Distribution and urinary excretion of the desethylmetabolites of chloroquine in the rat

  1987cited by this paper
• Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance.

  1987cited by this paper
• Urinary metabolism of chloroquine.

  1987cited by this paper
• The disposition of amodiaquine in man after oral administration.

  1987cited by this paper
• The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses.

  1987cited by this paper
• The relationship of the pharmacokinetics of chloroquine to dose in the rabbit

  1987cited by this paper
• Excretion of chloroquine and desethylchloroquine in human milk.

  1987cited by this paper
• Pharmacokinetics of intravenous amodiaquine.

  1987cited by this paper
• Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.

  1987cited by this paper
• Antimalarial interaction with ferriprotoporphyrin IX monomer and its relationship to activity of the blood schizontocides.

  1987cited by this paper
• Spread of chloroquine resistance in Plasmodium falciparum.

  1987cited by this paper
• Single dose disposition of chloroquine in kwashiorkor and normal children--evidence for decreased absorption in kwashiorkor.

  1987cited by this paper
• Multiple-drug resistance in human cancer.

  1987cited by this paper
• Liquid chromatographic determination of amopyroquine in rabbit plasma and red blood cells.

  1987cited by this paper
• Parenteral chloroquine for treating falciparum malaria.

  1987cited by this paper
• Whole blood concentrations of chloroquine and desethylchloroquine during and after treatment of adult patients infected with Plasmodium vivax, P. ovale or P. malariae.

  1986cited by this paper
• Saliva secretion of chloroquine in man

  1986cited by this paper
• Isolation, characterization and standardization of a major metabolite of amodiaquine by chromatographic and spectroscopic methods.

  1986cited by this paper
• Calcium antagonism and calcium entry blockade.

  1986cited by this paper
• Sensitive analysis of blood for amodiaquine and three metabolites by high-performance liquid chromatography with electrochemical detection.

  1986cited by this paper
• Amodiaquine induced agranulocytosis and liver damage.

  1986cited by this paper
• Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans.

  1986cited by this paper
• Cardiovascular toxicity and distribution kinetics of intravenous chloroquine.

  1986cited by this paper
• Chloroquine kinetics in normal and P. knowlesi infected rhesus monkeys.

  1985cited by this paper
• Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance

  1985cited by this paper
• Biotransformation de l'amodiaquine et prophylaxie du paludisme à plasmodium falciparum

  1985cited by this paper
• Intravenous amodiaquine and oral amodiaquine/erythromycin in the treatment of chloroquine-resistant falciparum malaria.

  1985cited by this paper
• Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans.

  1985cited by this paper
• [Biotransformation of amiodaquine and prophylaxis of Plasmodium falciparum malaria].

  1985cited by this paper
• Blood levels and in vitro activity of desethylchloroquine against Plasmodium falciparum.

  1984cited by this paper
• In vitro assessment of the antimalarial activity of chloroquine and its major metabolites.

  1984influential reference
• Pharmacokinetics of chloroquine in renal insufficiency.

  1984cited by this paper
• Identification of the acidic compartment of Plasmodium falciparum‐infected human erythrocytes as the target of the antimalarial drug chloroquine.

  1984cited by this paper
• Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya.

  1984cited by this paper
• Characterization of chloroquine plasma protein binding in man.

  1983cited by this paper
• Plasma, whole blood and red blood cell kinetics of chloroquine after oral and parenteral administration in rabbits.

  1983cited by this paper
• Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria.

  1983cited by this paper
• Disposition of chloroquine in man after single intravenous and oral doses.

  1983cited by this paper
• On the question of dose‐dependent chloroquine elimination of a single oral dose

  1983cited by this paper
• Plasma, whole blood and red blood cell kinetics of chloroquine after oral and parenteral administration in rabbits.

  1983cited by this paper
• Changing in vitro response to chloroquine of Plasmodium falciparum in Kenya.

  1983cited by this paper
• Kinetics of the uptake and elimination of chloroquine in children with malaria.

  1982cited by this paper
• Sensitive method for the determination of chloroquine and its metabolite desethyl-chloroquine in human plasma and urine by high-performance liquid chromatography.

  1980cited by this paper
• Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites.

  1980cited by this paper
• Long-term outcome after severe head injury.

  1979cited by this paper
• Pharmacokinetics of antimalarials and proposals for dosage regimens.

  1978cited by this paper
• Pharmacokinetics of antimalarials and proposals for dosage regimens.

  1978cited by this paper
• The binding of chloroquine to normal and Kwashiorkor serum.

  1977cited by this paper
• The Disposition and Metabolism of Amodiaquine in Small Mammals

  1974cited by this paper
• Plasmodium falciparum in Owl Monkeys: Drug Resistance and Chloroquine Binding Capacity

  1970cited by this paper
• THE METABOLISM OF CHLOROQUINE IN MAN DURING AND AFTER REPEATED ORAL DOSAGE

  1967cited by this paper
• The metabolism of chloroquine in man during and after repeated oral dosage.

  1967cited by this paper
• Tissue distribution of chloroquine, hydroxychloroquine, and desethylchloroquine in the rat.

  1967cited by this paper
• DNA: Reaction with Chloroquine

  1965cited by this paper
• Intramuscular amopyroquin for acute malaria.

  1962cited by this paper
• Laboratory studies on amopyroquin (propoquin), an antimalarial compound.

  1958cited by this paper
• Propoquin in treatment of malaria.

  1957cited by this paper
• Current Topics, Etc.

  1950cited by this paper
• STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VI. THE PHYSIOLOGICAL DISPOSITION, ANTIMALARIAL ACTIVITY, AND TOXICITY OF SEVERAL DERIVATIVES OF 4-AMINOQUINOLINE.

  1948cited by this paper

• Small Molecule Kinase Inhibitors with In Vitro β‐Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning

  2026cites this paper
• Structural and Functional Implications of MIT2 and NT2 Mutations in Amodiaquine and Piperaquine Resistant Plasmodium berghei Parasites.

  2025cites this paper
• Enhancing radiation sensitivity in malignant brain tumors with chloroquine: a systematic review

  2025cites this paper
• Hydroxychloroquine: Chemistry and Medicinal Applications

  2023cites this paper
• Multifunctional pH-responsive nanogel for malaria and cancer treatment: Hitting two targets with one arrow

  2022cites this paper
• Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19

  2022cites this paper
• The cinchona alkaloids and the aminoquinolines

  2020cites this paper
• Chloroquine against malaria, cancers and viral diseases

  2020cites this paper
• Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions

  2020cites this paper
• Toxicokinetics of hydroxychloroquine following a massive overdose.

  2019cites this paper
• Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing

  2018cites this paper
• Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine

  2018cites this paper
• Pharmacotherapy for the prevention of malaria in pregnant women: currently available drugs and challenges

  2018cites this paper
• Plasmodium vivax in Oceania

  2016cites this paper
• Pharmacokinetics and allometric scaling of antimalarial drugs

  2015cites this paper
• Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico

  2015cites this paper
• Interactions of the antimalarial amodiaquine with lipid model membranes.

  2015cites this paper
• DESIGN OF SIMPLE UV SPECTROPHOTOMETRIC AND HPLC METHODS FOR ASSAY OF ARTESUNATE AND AMODIAQUINE IN FIXED DOSE TABLET FORMULATIONS.

  2014cites this paper
• Identification and characterisation of small molecule inhibitors of feline coronavirus replication

  2014cites this paper
• "Recycling" classical drugs for malaria.

  2014cites this paper
• Novel antiviral strategies for feline coronavirus and feline calicivirus

  2014cites this paper
• Synthesis of a Potent Antimalarial Agent through Natural Products Conjugation

  2013cites this paper
• EVALUATION OF THE EFFICACY OF TRANSDERMAL DELIVERY OF CHLOROQUINE ON MALARIA PARASITES IN PLASMODIUM BERGHEI-INFECTED MALE SPRAGUE-DAWLEY RATS: EFFECTS ON BLOOD GLUCOSE AND RENAL ELECTROLYTE HANDLING

  2013cites this paper
• The role of molecular markers in emerging artemether-lumefantrine resistant Plasmodium falciparum

  2012cites this paper
• Population Pharmacokinetic and Pharmacodynamic Modeling of Amodiaquine and Desethylamodiaquine in Women with Plasmodium vivax Malaria during and after Pregnancy

  2012cites this paper
• Biowaiver monographs for immediate release solid oral dosage forms: amodiaquine hydrochloride.

  2012cites this paper
• Development, Evaluation, and Application of an In Silico Model for Antimalarial Drug Treatment and Failure

  2011cites this paper
• Human genetic variation is associated with Plasmodium falciparum drug resistance.

  2011cites this paper
• Effects of novel chloroquine formulation on blood glucose concentration, renal and cardiovascular function in experimental animal paradigms.

  2011cites this paper
• Plasmodium falciparum Resistance to Amodiaquine in Monotherapy and in Combination Therapy with Artesunate

  2010cites this paper
• Plasmodium falciparum response to chloroquine and artemisinin based combination therapy (ACT) in Guinea-Bissau

  2009cites this paper
• Chloroquine: novel uses & manifestations.

  2008cites this paper
• Effect of Concomitant Artesunate Administration and Cytochrome P4502C8 Polymorphisms on the Pharmacokinetics of Amodiaquine in Ghanaian Children with Uncomplicated Malaria

  2008cites this paper
• CYP2C8 and antimalaria drug efficacy

  2007cites this paper
• Treatment of uncomplicated malaria in Guinea-Bissau

  2006cites this paper
• IMIPRAMINE INDUCED COMPLETE REVERSAL OF CHLOROQUINE RESISTANCE IN PLASMODIUM FALCIPARUM INFECTIONS IN SUDAN

  2004cites this paper
• Characterization of chloroquine-hematin mu-oxo dimer binding by isothermal titration calorimetry.

  2000cites this paper
• The antiplasmodial activities of the tetramethylpiperidyl-substituted phenazines, B4119 and B4158

  1999cites this paper
• Quinine disposition in globally malnourished children with cerebral malaria

  1999cites this paper
• Amodiaquine: the exempted antimalarial drug in Ethiopia.

  1998cites this paper
• Modelling the chloroquine chemotherapy of falciparum malaria: the value of spacing a split dose

  1998cites this paper
• Novel Aryl‐bis‐quinolines with Antimalarial Activity In‐vivo

  1998cites this paper
• Compounds Chloroquine , and Structurally Related CpG-Oligodeoxynucleotides by Quinacrine , Antagonism of Immunostimulatory

  1998cites this paper
• Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog.

  1998cites this paper
• Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.

  1998cites this paper
• Phenotyping of the glutathione S-transferase M1 polymorphism in Zimbabweans and the effects of chloroquine on blood glutathione S-transferases M1 and A.

  1997cites this paper
• Chloroquine is a potent inhibitor of glutamate dehydrogenase in liver and kidney-cortex of rabbit.

  1997cites this paper
• Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine

  1997cites this paper
• Active efflux by multidrug transporters as one of the strategies to evade chemotherapy and novel practical implications of yeast pleiotropic drug resistance.

  1997cites this paper
• Pharmacokinetics of Quinine, Chloroquine and Amodiaquine

  1996cites this paper
• A P‐glycoprotein protects Caenorhabditis elegans against natural toxins.

  1995cites this paper
• New mechanisms of drug resistance in parasitic protozoa.

  1995cites this paper
• Morphological and Histological Evaluation of Developing Kidney in Rats Exposed to Chloroquine

  year unknowncites this paper